Journal article icon

Journal article : Review

Evaluating safety and quality of robotic-assisted gastric cancer surgery: meta-analysis and meta-regression

Abstract:
Background: Robotic-assisted surgery is expanding globally. The UK’s National Institute for Health and Care Excellence recently cautioned due to a paucity of high-quality evidence. To address this, a systematic review, meta-analysis, and meta-regression were undertaken to evaluate the quality and safety of robotic-assisted gastrectomy (RAG) versus conventional approaches for gastric cancer. Methods: Systematic searches were conducted on MEDLINE, Embase, Web of Science, and Scopus (2 May 2025) for studies comparing RAG to open or laparoscopic gastrectomy up to 30 April 2025. Primary outcomes were Clavien–Dindo grade ≥ II complications (CD ≥ II; safety) and margin-positive resections (quality). Risk of bias was assessed using the Risk Of Bias In Non-randomized Studies of Interventions and Cochrane Risk of Bias v2.0 tools. Heterogeneity and evidence certainty were evaluated using meta-regression and GRADE assessment. Results: In all, 90 studies (65 296 patients) were included; only three studies were randomized clinical trials and 72 were from East Asia. In 44 studies (12 102 patients) RAG was associated with significantly lower CD ≥ II complications (odds ratio (OR) 0.74; 95% confidence interval (c.i.) 0.64 to 0.86); heterogeneity was low (I2 = 21.4%). Seven studies had a low risk of bias. From 35 studies on margin status, RAG had fewer R1 resections (OR 0.74; 95% c.i. 0.51 to 1.07); heterogeneity was moderate (I2 = 34.0%). Adoption year, industry funding, extent of resection, and tumour stage were identified as sources of heterogeneity. Three studies were at low risk of bias. Certainty was very low for both outcomes. Conclusion: Although there may be potential benefits of robotic-assisted surgery, cautious adoption is warranted given the current uncertainty. Safe adoption requires standardized training, competency benchmarks, and limiting industry involvement. High-quality evaluation through randomized trials and parallel health economics is urgently needed to inform future policy and practice.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1093/bjsopen/zraf126

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Sub department:
Surgical Sciences
Role:
Author
ORCID:
0000-0002-2507-2006
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Sub department:
Surgical Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Surgical Sciences
Sub department:
Surgical Sciences
Role:
Author
More by this author
Role:
Author
ORCID:
0000-0002-2748-0011
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-8650-2017


More from this funder
Funder identifier:
https://ror.org/02qrg5a24
More from this funder
Funder identifier:
https://ror.org/0187kwz08


Publisher:
Oxford University Press
Journal:
BJS Open More from this journal
Volume:
9
Issue:
6
Article number:
zraf126
Publication date:
2025-11-24
Acceptance date:
2025-08-24
DOI:
EISSN:
2474-9842
ISSN:
2474-9842


Language:
English
Keywords:
Subtype:
Review
Pubs id:
2341014
UUID:
uuid_7b5b3013-cb9c-4ea6-ba1d-60fe79b01083
Local pid:
pubs:2341014
Source identifiers:
3500992
Deposit date:
2025-11-24
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP